中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共5条，第1-5条 帮助

已选(0)清除 条数/页：   排序方式：
Neoadjuvant immunotherapy in non-small-cell lung cancer: a narrative review on mechanisms, efficacy and safety 期刊论文
JOURNAL OF THORACIC DISEASE, 2022
作者:  Shao, Lan;  Lou, Guangyuan
收藏  |  浏览/下载：39/0  |  提交时间：2022/12/22
Neoadjuvant  immunotherapy  immune-checkpoint inhibitors  non-small cell lung cancer (NSCLC)  
Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial 期刊论文
LANCET ONCOLOGY, 2022, 卷号: 23
作者:  Zhou, Qing;  Chen, Ming;  Jiang, Ou;  Pan, Yi;  Hu, Desheng;  Lin, Qin;  Wu, Gang;  Cui, Jiuwei;  Chang, Jianhua;  Cheng, Yufeng;  Huang, Cheng;  Liu, Anwen;  Yang, Nong;  Gong, Youling;  Zhu, Chuan;  Ma, Zhiyong;  Fang, Jian;  Chen, Gongyan;  Zhao, Jun;  Shi, Anhui;  Lin, Yingcheng;  Li, Guanghui;  Liu, Yunpeng;  Wang, Dong;  Wu, Rong;  Xu, Xinhua;  Shi, Jianhua;  Liu, Zhihua;  Cui, Na;  Wang, Jingru;  Wang, Qiang;  Zhang, Ran;  Yang, Jason;  Wu, Yi-Long
收藏  |  浏览/下载：71/0  |  提交时间：2022/03/21
ORIENTAL: An open label, multicenter, phase IIIb study of first-line durvalumab plus platinum-based chemotherapy in Chinese patients with extensive stage small cell lung cancer (ES-SCLC) 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2021, 卷号: 16
作者:  Cheng, Y.;  Wang, J.;  Cang, S.;  Cao, L.;  Chen, E.;  Dong, X.;  Fan, Y.;  Gao, B.;  Guo, Q.;  Huang, D.;  Li, S.;  Liu, A.;  Lv, D.;  Pan, Y.;  Tang, K.;  Yao, W.;  Ye, F.;  Yu, Y.;  Zang, A.;  Gao, M.
收藏  |  浏览/下载：50/0  |  提交时间：2021/04/26
Cost-effectiveness analysis of durvalumab plus etoposide: platinum in the first-line therapy of extensive stage small-cell lung cancer from the Chinese payers' perspective 期刊论文
TUMORI JOURNAL, 2021
作者:  Tong, Ying-hui;  Ding, Hai-ying;  Xin, Wen-xiu;  Zhong, Li-ke;  Xu, Gao-qi;  Zhang, Bo;  Yang, Guo-nong;  Fang, Luo
收藏  |  浏览/下载：50/0  |  提交时间：2021/08/30
Cost-effectiveness  durvalumab  etoposide plus platinum chemotherapy  first-line treatment  SCLC  
Durvalumab monotherapy as a third-line treatment for extensive-stage small-cell lung cancer: a case report 期刊论文
ANNALS OF PALLIATIVE MEDICINE, 2020, 卷号: 9
作者:  Zhou, Qinfei;  Zhao, Jiazheng;  Wang, Jie;  Bao, Guanai;  Gong, Li-Yan
收藏  |  浏览/下载：39/0  |  提交时间：2020/11/26
Small-cell lung cancer (SCLC)  immunotherapy  durvalumab  third-line treatment  case report